血清的季节性变化和相关的处方模式:生态时间序列
Rasiah Thayakaran1, Richard Hotham1, Krishna M Gokhale1
1Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Journal of clinical pathology
|June 6, 2023
概括
环境温度影响血清,影响药物选择. 较低的温度与较高的水平相关,导致更多的ACE抑制剂处方和较少的补充剂.
科学领域:
- 环境健康 环境健康
- 临床药理学 临床药理学
- 心脏病学 心脏病学
背景情况:
- 血清水平呈季节性变化,可能影响临床决策.
- 环境温度是影响血清等生理参数的重要因素.
研究的目的:
- 调查环境温度,血清水平和ACE抑制剂和补充剂的处方模式之间的关联.
- 评估季节性变量的影响临床决策在一个大患者队列.
主要方法:
- 来自英国初级保健数据集的1,218,453名成年患者的生态时间序列分析.
- 准-普森回归建模来检查每月血清,ACE抑制剂处方和补充剂处方之间的关联.
- 对血清和处方药的季节性模式的分析.
主要成果:
- 血清水平表现出季节性模式,冬季达到峰值,夏季降至最低.
- 补充剂的处方在夏季增加,这与血清水平降低相吻合.
- 在冬季,ACE抑制剂的处方增加,与较高的血清相关 (RR 1.33).
- 补充的处方在冬季下降 (RR 0.37).
结论:
- 血清水平的季节性变化是显而易见的,并且影响了对敏感药物的处方做法.
- 临床医生应了解的季节性变化,以避免误解结果,并确保适当的处方.
- 了解血清的季节性影响对于准确的临床决策和药物管理至关重要.
更多相关视频
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
658
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
658
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
93
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
93
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
171
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
171
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
Regulation of Sodium and Potassium
630
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
630
Antiepileptic Drugs: Potassium Channel Activators
219
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
219


